All About Value – Brexit Aside, UK Industry Sees Good Things Ahead For Healthtech Adoption
The ethos of rewarding value and new channels to promote medtech innovation are gaining ground in the UK
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.
You may also be interested in...
Hoping For A New Dawn In UK’s Value-Based Procurement
The UK’s MedTech Directorate is undergoing a partial relaunch, with a new director set to take the reins and a new strategy being finalized. The medtech industry hopes the renewed impetus will put long-overdue attention to value-based procurement for medtech goods.
COVID-Delayed UK Medtech Mandate Previews First Products For NHS Adoption
The Medtech Mandate, a scheme that seeks to better match NICE guidance with adoption and use of medtech innovations in the UK, is preparing for launch in April.
NHSX Brings A New Digital Dimension In UK
The UK continues to build its digital health care infrastructure, as seen in the recent funding pledge for a new AI Lab. Andrew Davies is the newly appointed digital health lead at the UK’s ABHI medtech industry association. He says stakeholders first need to understand the scope of digital health care, and then adopt a networked approach, with medtech playing a full part in that evolution.